Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eli Lilly And Co (LLY) vs Qnity Electronics Inc. Common Stock (Q) Price & Performance

Eli Lilly And CoTrade
Qnity Electronics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Qnity Electronics Inc. Common Stock — how do they compare? Eli Lilly And Co trades at $1,177.77 (market cap $1.04T), while Qnity Electronics Inc. Common Stock trades at $125.47 (market cap $26.50B). The key difference: Eli Lilly And Co is far larger — about 39.2× Qnity Electronics Inc. Common Stock's market cap, and Eli Lilly And Co pays the higher dividend (0.59%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Qnity Electronics Inc. Common Stock for 1 Days on average.

LLYQ
Market Cap
$1.04T$26.50B
Volume
3,064,8781,501,084
Sector
HealthTechnology
52-Week High
$1.28K$175.64
52-Week Low
$799.57$73.54
Typical Hold Time
93 Days1 Days
Enterprise Value
$1.09T$29.56B
Dividend Yield
0.59%0.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,179.27, down 0.79% on the day, with a bullish technical outlook and strong fundamental momentum. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 expectation. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing its market leadership.

The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include competitive pressures in the obesity drug market and execution challenges in scaling production. With a consensus price target of $1,350, representing ~14% upside, the stock offers growth potential but requires monitoring of pipeline progress and market dynamics.

Qnity Electronics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LLY
22% Buy78% Sell
Avg holding period · 93 Days
Q

No sentiment data available yet.

Top news

Latest headlines on both assets

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY →

About Qnity Electronics Inc. Common Stock

Qnity Electronics provides materials and solutions for semiconductor manufacturing and electronic systems. Its portfolio supports chip fabrication, advanced packaging, interconnects, and thermal management.

Read more on Q →